Mechanism-based approaches for the reversal of drug neurobehavioral teratogenicity

Joseph Yanai1, Tamar L Ben-Shaanan, Hana Haimovitch

  • 1The Ross Laboratory for Studies in Neural Birth Defects, Department of Anatomy and Cell Biology, The Hebrew University-Hadassah Medical School, Box 12272, 91010 Jerusalem, Israel. yanai@md.huji.ac.il

Insights

Neurobehavioral teratogenicity from drugs like heroin can be reversed. Nicotine infusion or neural progenitor grafting can correct hippocampus-related behavioral deficits caused by these toxins.

Area of Science:

  • Neuroscience
  • Developmental Neuroscience
  • Pharmacology

Background:

  • Neurobehavioral teratogenicity, resulting from prenatal exposure to toxins, presents significant challenges in understanding and treatment.
  • Hippocampus-dependent behaviors are particularly vulnerable to teratogenic insults, impacting cognitive development.
  • Identifying specific neurochemical pathways affected by teratogens is crucial for developing targeted interventions.

Purpose of the Study:

  • To elucidate the mechanism of neurobehavioral deficits induced by cholinergic teratogens, focusing on hippocampus-related behaviors.
  • To investigate the potential for reversing these teratogen-induced deficits using pharmacological and cellular therapies.
  • To establish a model for understanding and treating neurobehavioral birth defects.

Main Methods:

  • Utilized an animal model to study teratogen-induced deficits in eight-arm and Morris maze tasks, which are hippocampus-dependent.
  • Investigated the effects of cholinergic teratogens (e.g., heroin) on hippocampal cholinergic innervation and Protein Kinase C (PKC) signaling.
  • Evaluated the efficacy of nicotine infusion and neural progenitor grafting in reversing observed behavioral and molecular alterations.

Main Results:

  • Heroin exposure induced pre- and postsynaptic hyperactivity in hippocampal cholinergic innervation, leading to PKC isoform desensitization.
  • Nicotine infusion successfully reversed these teratogen-induced deficits and improved maze performance.
  • Grafting of embryonic cholinergic cells or neural progenitors also reversed biochemical alterations and behavioral deficits, with progenitor grafting showing higher efficacy.

Conclusions:

  • Understanding the specific neurochemical mechanisms of teratogenicity is key to developing effective reversal strategies.
  • Pharmacological interventions, such as nicotine infusion, offer a feasible and immediate therapeutic approach for neurobehavioral birth defects.
  • Neural progenitor grafting represents a promising, albeit more complex, treatment for reversing teratogen-induced neurodevelopmental abnormalities.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...